Tomáš Jelı́nek

Researcher Next ID · RN-041719

Researcher · Biochemistry, Genetics and Molecular Biology

Ostrava, Czechia

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Multiple Myeloma Research and Treatments

Boron Compounds in Chemistry

Malaria Research and Control

Mosquito-borne diseases and control

Protein Degradation and Inhibitors

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Clinical Infectious Diseases · 2024 · https://doi.org/10.1093/cid/ciae010
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research · 2019 · https://doi.org/10.1158/1078-0432.ccr-18-1597
Imported Falciparum Malaria in Europe: Sentinel Surveillance Data from the European Network on Surveillance of Imported Infectious Diseases
Clinical Infectious Diseases · 2002 · https://doi.org/10.1086/338235
Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop
Clinical Infectious Diseases · 2002 · https://doi.org/10.1086/342906
Isolation of High-Affinity Peptide Antagonists of 14-3-3 Proteins by Phage Display
Biochemistry · 1999 · https://doi.org/10.1021/bi991353h
Reversal of Raf-1 Activation by Purified and Membrane-Associated Protein Phosphatases
Science · 1995 · https://doi.org/10.1126/science.7604263
Inhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate
Science · 1993 · https://doi.org/10.1126/science.7694366

No projects listed.